How a Deadly Superbug Tricks the Immune System to Survive in Hair Follicles
discovermagazine - Learn how Candida auris takes advantage of the skin’s immune response to stay put inside hair follicles.
AI Summary: Researchers show that Candida auris can persist in hair follicles by rewiring local skin immune responses, creating a hidden reservoir that helps the fungus survive disinfection and spread in healthcare settings. The finding explains persistent colonization and suggests new diagnostic and decolonization strategies focused on follicular niches — because apparently this pathogen likes a good hairdo.
Fridge-free tetanus-diphtheria vaccine shows promise of reaching millions worldwide
medicalxpress - The encouraging results of the world's first trial of a fridge-free tetanus-diphtheria vaccine could improve access worldwide to crucial treatments while reducing carbon emissions. Fridge-free vaccines have the potential to transform vaccine delivery by r…
AI Summary: Early studies of fridge‑free vaccine formulations, including a tetanus‑diphtheria candidate, indicate stability without cold storage, promising to reduce discarded doses and simplify distribution in low‑resource settings. If these results hold up, the change could shrink logistical headaches, boost global immunization reach and finally make the vaccine refrigerator’s light a little less terrifying.
Senate Confirms Dr. Erica Schwartz as C.D.C. Director
Apoorva Mandavilli / nytimes - Dr. Schwartz, a deputy surgeon general in the first Trump administration, has publicly supported childhood vaccines.
AI Summary: Senate confirmed Dr. Erica Schwartz as director of the Centers for Disease Control and Prevention after a high-profile nomination process. She will assume leadership of the agency responsible for national disease prevention and public health preparedness, steering CDC policy and operations amid ongoing public‑health challenges and scrutiny of federal responses.
Single dose of psilocybin for depression shows promising results in UK's first publicly funded randomized trial
medicalxpress - The first randomized controlled trial in the U.K. has found that a single dose of psilocybin, the active compound found in "magic mushrooms," produced significant improvements in depression compared with a placebo. This is the first publicly funded random…
AI Summary: A publicly funded randomized trial in the UK found that a single dose of psilocybin, delivered in a clinical setting, produced promising improvements for people with treatment-resistant major depressive disorder. The results suggest psychedelic-assisted therapy could be a viable addition to standard care—pending larger trials and careful safety monitoring—challenging old assumptions about one-and-done fixes.
Some COVID-19 Patients Suffered Heart Damage, an Overlooked Coronavirus Protein May Explain Why
discovermagazine - Discover how the inconspicuous nucleocapsid protein from coronaviruses can trigger hyperinflammation, an effect not typically seen in other viruses.
AI Summary: Scientists identified a previously underappreciated SARS‑CoV‑2 protein that appears to damage heart tissue and may help explain persistent post‑COVID symptoms. The study ties the viral molecule to mechanisms of cardiac injury, opening diagnostic and therapeutic research paths for long COVID cardiac effects — proof that sometimes the troublemaker was hiding in plain sight.
New bipartisan 340B reform bill curbs HHS' rebate pilot
fiercehealthcare - The SUSTAIN 340B Act introduced Wednesday would bring hospital-backed changes, like a clearinghouse to handle improper discounts, and codifies longstanding grey areas in the contentious subsidy program.
AI Summary: Bipartisan lawmakers introduced legislation to rein in HHS’s controversial 340B rebate pilot, pushing back on administrative changes that providers say threaten safety‑net funding. The bill aims to pause or limit the pilot while stakeholders debate drug‑pricing impacts, reimbursements and patient access — the predictable Washington policy scrum.